Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Double Dummy, Randomized Comparison Study Of The Efficacy And Safety Of Valdecoxib 10mg QD And Naproxen 500mg BID In Treating The Signs And Symptoms Of Osteoarthritis Of The Knee Or Hip In Taiwan

NCT00648258 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00648258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00648258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Double Dummy, Randomized Comparison Study Of The Efficacy And Safety Of Valdecoxib 10mg QD And Naproxen 500mg BID In Treating The Signs And Symptoms Of Osteoarthritis Of The Knee Or Hip In Taiwan
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2003
Completion date
April 30, 2004
Enrollment
130 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis